Summary
The termination of responses to noradrenaline and adrenaline was studied, using the oil immersion technique, in helically cut strips obtained from the lateral saphenous vein of the dog. Inhibitors of catechol-O-methyltransferase (tropolone), monoamine oxidase (iproniazid) or neuronal uptake (cocaine and imipramine-N-oxide) slowed the relaxation rate of strips contracted by noradrenaline or adrenaline (10−5 and 10−6 M) and immersed in oil. From these experiments it is concluded that, at the concentrations used, oxidative deamination represents the major inactivation pathway for both catecholamines, and that O-methylation plays only a minor role in the disposition of the amines; however, the inactivation of adrenaline is more dependent on catechol-O-methyltransferase than that of noradrenaline. Tissue uptake and storage occupied an intermediate position between the enzymatic pathways referred to: iproniazid inhibited 79%, cocaine 54% and tropolone 27% of the inactivation capacity when 10−5 M noradrenaline was used. However, the combination of the three drugs inhibited only 88% of the inactivation capacity. This is due to the marked overlap of the effects of cocaine and iproniazid, which is attributed to the blockade by cocaine of the access of the amine to intraneuronal sites of oxidative deamination.
Cocaine caused marked potentiation of responses to noradrenaline and moderate prolongation of relaxation time, while iproniazid, which had much more marked effects on the termination of action of noradrenaline, induced only a slight augmentation of the contractile responses. It is concluded that potentiation is an unreliable index of altered disposition of noradrenaline in this preparation.
Experiments with perfused venous segments showed that, following the concentration gradient, noradrenaline diffuses freely through the vein wall, and that there is no marked difference in responses to adventitial or intimal application of the amine. Radioautographic studies gave evidence of two different types of accumulation (neuronal and extraneuronal), which appeared to be in equilibrium.
Similar content being viewed by others
References
Avakian, O. V., Gillespie, J. S.: Uptake of noradrenaline by adrenergic nerves, smooth muscle and connective tissue in isolated perfused arteries and its correlation with the vasoconstrictor response. Brit. J. Pharmacol.32, 168–184 (1968).
Axelrod, J., Albers, W., Clemente, C. D.: Distribution of catechol-O-methyltransferase in the nervous system and other tissues. J. Neurochem.5, 68–75 (1959a).
—, Weil-Malherbe, H., Tomchick, R.: The physiological disposition of H3-epinephrine and its metabolite metanephrine. J. Pharmacol. exp. Ther.127, 251–256 (1959b).
Bevan, J. A., Osher, J. V., Bevan, R. D.: Distribution of bound norepinephrine in the arterial wall. Europ. J. Pharmacol.6, 299–301 (1969).
Blaschko, H., Burn, J. H.: Oxidation of adrenaline and noradrenaline by amine oxidase. J. Physiol. (Lond.)112, 37 P (1951).
Burn, J. H., Robinson, J.: Noradrenaline and adrenaline in vessels of the rabbit ear in relation to the action of amine oxidase. Brit. J. Pharmacol.6, 101–109 (1951).
De la Lande, I. S., Cannell, V. A., Waterson, J. G.: The interaction of serotonine and noradrenaline on the perfused artery. Brit. J. Pharmacol.28, 255–272 (1966).
—, Frewin, D., Waterson, J. G.: The influence of sympathetic innervation on the vascular sensitivity to noradrenaline. Brit. J. Pharmacol.31, 82–93 (1967).
Descarries, L., Droz, B.: Intraneural distribution of exogenous norepinephrine in the central nervous system of the rat. J. Cell Biol.44, 385–399 (1970).
Draskóczy, P. R., Trendelenburg, U.: Intraneuronal and extraneuronal accumulation of sympathomimetic amines in the isolated nictitating membrane of the cat. J. Pharmacol. exp. Ther.174, 290–306 (1970).
Ehinger, B., Falck, B., Sporrong, B.: Adrenergic fibres to the heart and to peripheral vessels. Bibl. anat. (Basel)8, 35–45 (1966).
Elfvin, L.-G., Appelgren, L. E., Ullberg, S.: High-resolution autoradiography of the adrenal medulla after injection of tritiated dihydroxiphenylalanine (Dopa). J. Ultrastruct. Res.14, 277–293 (1966).
Ettisch, G., Gomes da Costa, S. F.: Biological effects of not-aqueous solutions. Arq. Pat. (Lisboa)8, 1–12 (1936).
— —: Sur la possibilité d'utilisation des huiles comme liquides de perfusion. C. R. Soc. Biol. (Paris)125, 560–562 (1937).
Furchgott, R. F., Bhadrakom, S.: Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs. J. Pharmaol. exp. Ther.,108, 129–143 (1953).
—, Kirpekar, S. M., Rieker, M., Schwab, A.: Actions and interactions of norepinephrine, tyramine and cocaine an aortic strips of rabbit and left atria of guinea pig and cat. J. Pharmacol. exp. Ther.142, 39–58 (1963).
Gillespie, J. S., Hamilton, D. N. H.: A possible active transport of noradrenaline into arterial smooth muscle cells. J. Physiol. (Lond.)192, 30 P (1937).
Gryglewski, R., Vane, J. R.: The inactivation of noradrenaline and isoprenaline in dogs. Brit. J. Pharmacol.39, 573–584 (1970).
Guimarães, S., Osswald, W.: Adrenergic receptors in the veins of the dog. Europ. J. Pharmacol.5, 133–140 (1969).
Haefely, W., Huerlimann, A., Thoenen, H.: A quantitative study of the effect of cocaine on the response of the cat nictitating membrane to nerve stimulation and to injected noradrenaline. Brit. J. Pharmacol.22, 5–21 (1964).
Haeusler, G., Haefely, W.: Pre- and postjunctional supersensitivity of the mesenteric artery preparation from normotensive and hypertensive rats. Naunyn-Schmiedebergs Arch. Pharmak.266, 18–33 (1970).
Heim, F.: Über den Einfluß verschiedener Ester auf die fermentative Oxydation von Adrenalin und Adrenalinderivaten. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.209, 181–193 (1950).
Iversen, L. L.: The uptake and storage of noradrenaline in sympathetic nerves. Cambridge: Cambridge University Press 1967.
Kalsner, S., Nickerson, M.: A method for the study of mechanisms of drug disposition in smooth muscle. Canad. J. Physiol. Pharmacol.46, 719–730 (1968a).
— —: Disposition of phenylephrine in vascular tissue, determined by the oilimmersion technique. J. Pharmacol. exp. Ther.163, 1–10 (1968b).
— —: Disposition of norepinephrine and epinephrine in vascular tissue, determined by the technique of oil immersion. J. Pharmacol. exp. Ther.165, 152–165 (1969a).
— —: Effects of reserpine on the disposition of sympathomimetic amines in vascular tissue. Brit. J. Pharmacol.35, 394–405 (1969b).
Kalsner, S., Nickerson, M.: Mechanism of cocaine potentiation of responses to amines. Brit. J. Pharmacol.35, 428–439 (1969c).
— —: Effects of a haloalkylamine on responses to and disposition of sympathomimetic amines. Brit. J. Pharmacol.35, 440–455 (1969d).
Kopin, I. J.: Storage and metabolism of catecholamines: The role of monoamine oxidase. Pharmacol. Rev.16, 179–191 (1964).
Levin, J. A., Furchgott, R. F.: Interactions between potentiating agents of adrenergic amines in rabbit aortic strips. J. Pharmacol. exp. Ther.172, 320 to 331 (1970).
Luft, J. H.: Improvements in epoxy embedding methods. J. biophys. biochem. Cytol.9, 409–414 (1961).
MacMillan, W. H.: A hypothesis concerning the effect of cocaine on the action of sympathomimetic amines. Brit. J. Pharmacol.14, 385–391 (1959).
Muscholl, E.: Effect of cocaine and related drugs on the uptake of noradrenaline by heart and spleen. Brit. J. Pharmacol.16, 352–359 (1961).
Norberg, K.-A., Hamberger, B.: The sympathetic adrenergic neuron. Acta physiol. scand.63, suppl. 238, 5–42 (1964).
Smith, C. B., Trendelenburg, U., Langer, S. Z., Tsai, T. H.: The relation of retention of norepinephrine-3H to the norepinephrine content of the nictitating membrane of the spinal cat during development of denervation supersensitivity. J. Pharmacol. exp. Ther.151, 87–94 (1966).
Somlyo, A. P., Somlyo, A. V.: Vascular smooth muscle. I. Normal structure, pathology, biochemistry and biophysics. Pharmacol. Rev.20, 197–272 (1968).
Trendelenburg, U.: Supersensitivity by cocaine to dextrorotatory isomers of norepinephrine and epinephrine. J. Pharmacol. exp. Ther.148, 329–338 (1965).
—: Mechanisms of supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol. Rev.18, 629–640 (1966).
—, Muskus, A., Fleming, W. W., Gomez Alonso de la Sierra, B.: Effect of cocaine, denervation and decentralization on the response of the nictitating membrane to various sympathomimetic amines. J. Pharmacol. exp. Ther.138, 181–193 (1962).
Vane, J. R.: The release and fate of vasoactive hormones in the circulation. Brit. J. Pharmacol.35, 209–242 (1969).
Vanhoutte, P. M., Shepherd, J. T.: Activity and thermosensitivity of canine cutaneous veins after inhibition of monoamine oxidase and catechol-o-methyl transferase. Circulat. Res.25, 607–616 (1969).
Whitby, L. G., Hertting, G., Axelrod, J.: Effect of cocaine on the disposition of noradrenaline labelled with tritium. Nature (Lond.)187, 604–605 (1960).
Author information
Authors and Affiliations
Additional information
Supported in part by a grant from III Plano de Fomento (Actividades, 1970).
Rights and permissions
About this article
Cite this article
Osswald, W., Guimarães, S. & Coimbra, A. The termination of action of catecholamines in the isolated venous tissue of the dog. Naunyn-Schmiedebergs Arch. Pharmak. 269, 15–31 (1971). https://doi.org/10.1007/BF01422013
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01422013